Radiology Patient Action Network Urges Congress and CMS to Prevent ‘Cruel’ Cuts to Medicare Access
"With nearly half of Medicare-eligible women having gone years without receiving a mammogram," noted Bob Still, the Executive Director of...
Year: 2023
Remote Monitoring and Teledentistry App In Hand Dental Partners With Five Star Orthodontic Laboratory & Supply, Inc.
Five Star Orthodontic Laboratory & Supply, Inc. has been servicing the Orthodontic community for over 30 years. They will be...
Pressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering
During Interview with "Cannabis Talks" (Cannabis and Hemp Insider), CEO Ric Schumacher Reveals Transition into Aggressive Growth Phase for Revolutionary...
Health Karma Group Announces a Strategic Partnership with Wanido for Employee-Centric Companies
FORT LAUDERDALE, FL / ACCESSWIRE / July 17, 2023 / MediXall Group Inc. (OTC PINK:MDXL) Health Karma Inc, an innovative...
Intellihealth’s Flyte Medical Partners With RiverSpring Living to Offer Customized Employee Wellness Plans
Clinically proven approach helps individuals achieve and maintain weight goalsNEW YORK--(BUSINESS WIRE)--#Healthcare--Intellihealth, a leading health-tech software and clinical services company...
IMO’s Newest Products Tackle Standardizing Unstructured Text, Managing Value Sets, and Delivering Problem List Insights
CHICAGO--(BUSINESS WIRE)--Intelligent Medical Objects (IMO), a healthcare data enablement Company, announced today three new products for general availability: IMO Precision...
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
Advancing Next-Generation Wearable Patient Engagement and Diagnostic Technology Designed to Enable More Efficient Detection of Eye DiseasesALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos...
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
DENVER, CO / ACCESSWIRE / July 17, 2023 / Laxxon Medical, a leading 3D screen printing pharma-technology company, announced today...
STEMTECH (OTCQB: STEK) Shatters Records with Surge in New Recruits, Paving the Way for a Thrilling Era of Opportunity in the Booming Global Stem Cell Market
Growth Sparks Excitement as STEMTECH Achieves Record-Breaking Surge in New Independent Business PartnersMIRAMAR, FL / ACCESSWIRE / July 17, 2023...
UniDoc Introduces Artificial Intelligence (AI) Integration
AI software adds powerful diagnostic monitoring and assessment features and benefits.VANCOUVER, BC / ACCESSWIRE / July 17, 2023 / UniDoc...
Elektrofi Appoints Victoria Sluzky as Chief Technology Officer to Drive Innovation and Technical Excellence
BOSTON, July 17, 2023 (GLOBE NEWSWIRE) -- Today Elektrofi, a biopharmaceutical formulation technology company focused on leveraging strategic partnerships to...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
With a standard review, FDA set a PDUFA target action date of May 16, 2024FORT LEE, N.J., July 17, 2023...
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology...
Justera Health Signs Definitive Agreement to Acquire Juillet Wellness Centre
Toronto, Ontario--(Newsfile Corp. - July 17, 2023) - Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the...
IRLAB’s Phase IIb Study with Pirepemat Passes DSMB Safety Review with Unanimous Recommendation to Continue the Ongoing Phase IIb Study
GOTHENBURG, SWEDEN / ACCESSWIRE / July 17, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July 17, 2023 - IRLAB Therapeutics...
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease Small molecule varoglutamstat,...
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Figure 1 Acumen Pharmaceuticals, Inc. Figure 2 Acumen Pharmaceuticals, Inc.Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating...
Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or...
Atlas Global Brands Announces Delay in Annual and Interim Filings Following Complex Reverse Takeover, Acquisitions and Corporate Restructuring
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, July 14, 2023 (GLOBE NEWSWIRE) -- Atlas Global Brands Inc. (“Atlas Global” or the “Company”)...
Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement
TORONTO, July 14, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or...